Tower Research Capital (TRC)’s Mangoceuticals MGRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGRX
Tower Research Capital (TRC)'s MGRX Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Mangoceuticals (MGRX) stake by 2.6% in Q3 2026, selling an estimated $9 and leaving 763 shares worth $327. The position accounts for ﹤0.01% of the portfolio, ranked #5619.
Tower Research Capital (TRC) first reported a position in MGRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.37K in Q4 2024. 19 funds tracked by Wall St. Rank hold MGRX as of Q3 2026.
- Tower Research Capital (TRC) held 763 shares of Mangoceuticals worth $327 as of Q3 2026.
- Tower Research Capital (TRC) sold 20 Mangoceuticals shares in Q3 2026, an estimated $9.
- Mangoceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5619 holding.
- Tower Research Capital (TRC) first reported a position in Mangoceuticals in Q4 2024 and has held it in 7 quarters since.
- Tower Research Capital (TRC)'s Mangoceuticals position peaked at $6.37K in Q4 2024.
- 19 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.